- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: quadrivalent vaccine pregnant women.
Displaying page 1 of 1.
EudraCT Number: 2016-004763-40 | Sponsor Protocol Number: GQM14 | Start Date*: 2017-04-05 |
Sponsor Name:Sanofi Pasteur | ||
Full Title: Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra™) in Pregnant Women | ||
Medical condition: Prophylaxix of influenza in Pregnant Women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002932-42 | Sponsor Protocol Number: V501-110-01 | Start Date*: 2016-12-14 |
Sponsor Name:MSD K.K., a subsidiary of Merck & Co., Inc | ||
Full Title: A Phase IV Open-label, Descriptive Study to Evaluate the Safety and Effectiveness on the Incidence of HPV 6, 11, 16 and 18 Related CIN 2/3 or worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 ... | ||
Medical condition: Human Papillomavirus infection | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-000357-26 | Sponsor Protocol Number: 214709 | Start Date*: 2021-09-14 |
Sponsor Name:GlaxoSmithKline S.A. | ||
Full Title: A Phase III, observer-blind, randomized, multi-country study to evaluate the lot-to-lot consistency of GSK’s investigational RSV maternal vaccine and the immune response, safety and reactogenicity ... | ||
Medical condition: Healthy volunteers (prevention of RSV-associated lower respiratory tract illnesses (LRTIs)) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Temporarily Halted) FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004501-30 | Sponsor Protocol Number: V181-003 | Start Date*: 2022-06-14 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [live, attenuated]) ... | |||||||||||||
Medical condition: Prevention of dengue disease in toddlers, children, and adults in endemic areas, as well as travelers to endemic areas | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-001144-29 | Sponsor Protocol Number: V501-213 | Start Date*: 2024-01-12 |
Sponsor Name:Merck Sharp & Dohme LLC | ||
Full Title: A Phase 3 Open-Label Clinical Trial to Study the Immunogenicity, Safety and Tolerability of Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine (V501) in Chinese Girls Aged ... | ||
Medical condition: Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.